Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection.
Juan Manuel CoyaLaura De MatteisAlexandre Giraud-GatineauAnne BitonInés Serrano-SevillaAnne DanckaertMarie-Agnès DilliesBrigitte GicquelJesus M De la FuenteLudovic TailleuxPublished in: Journal of nanobiotechnology (2019)
The ability to modulate cell metabolism by grafting ligands at the surface of nanoparticles may thus be a promising strategy to reprogram immune cells and improve the efficacy of encapsulated drugs.